These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 9580744)

  • 1. Toremifene and letrozole for advanced breast cancer.
    Med Lett Drugs Ther; 1998 Apr; 40(1024):43-5. PubMed ID: 9580744
    [No Abstract]   [Full Text] [Related]  

  • 2. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
    Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A
    J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aromatase inhibitors: anastrozole versus tamoxifen as first-ine therapy for advanced postmenopausal breast cancer].
    Bergmann L
    Strahlenther Onkol; 2001 May; 177(5):273-4. PubMed ID: 11398617
    [No Abstract]   [Full Text] [Related]  

  • 4. New treatment option for postmenopausal women with early breast cancer.
    Expert Rev Anticancer Ther; 2002 Dec; 2(6):617. PubMed ID: 12503198
    [No Abstract]   [Full Text] [Related]  

  • 5. The Letrozole Breast Cancer Trial: clinical implications and remaining questions.
    Chen WY; Manson JE
    Womens Health Issues; 2004; 14(1):7-10. PubMed ID: 15001182
    [No Abstract]   [Full Text] [Related]  

  • 6. Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer.
    Miller WR; Stuart M; Sahmoud T; Dixon JM
    Br J Cancer; 2002 Oct; 87(9):950-5. PubMed ID: 12434282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of aromatase inhibitors in postmenopausal women with advanced breast cancer.
    Roseman BJ; Buzdar AU; Singletary SE
    J Surg Oncol; 1997 Nov; 66(3):215-20. PubMed ID: 9369969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focus on anastrozole and breast cancer.
    Mokbel K
    Curr Med Res Opin; 2003; 19(8):683-8. PubMed ID: 14687437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New breast cancer drug.
    Brink S
    US News World Rep; 2001 Dec; 131(26):52. PubMed ID: 11793594
    [No Abstract]   [Full Text] [Related]  

  • 10. Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer.
    Cohen MH; Johnson JR; Li N; Chen G; Pazdur R
    Clin Cancer Res; 2002 Mar; 8(3):665-9. PubMed ID: 11895893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Superiority of letrozole compared with tamoxifen as first line therapy of postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group].
    Illiger HJ
    Strahlenther Onkol; 2002 Feb; 178(2):111-3. PubMed ID: 11942036
    [No Abstract]   [Full Text] [Related]  

  • 12. Letrozole improves disease-free survival vs tamoxifen in adjuvant treatment of early breast cancer.
    Oncology (Williston Park); 2005 Mar; 19(3):277, 360. PubMed ID: 15828547
    [No Abstract]   [Full Text] [Related]  

  • 13. Tamoxifen vs the aromatase inhibitors: news from San Antonio, 2001.
    Munster PN; Horton J
    Cancer Control; 2001; 8(6):478-9. PubMed ID: 11807416
    [No Abstract]   [Full Text] [Related]  

  • 14. A better medication for treating breast cancer?
    Johns Hopkins Med Lett Health After 50; 2002 May; 14(3):3. PubMed ID: 12004835
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of hormone receptor status on the clinical efficacy of the new-generation aromatase inhibitors: a review of data from first-line metastatic disease trials in postmenopausal women.
    Buzdar AU; Vergote I; Sainsbury R
    Breast J; 2004; 10(3):211-7. PubMed ID: 15125747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiestrogen therapy in the treatment of breast neoplasms].
    Alba E; Ragonesi G; Colla F; Mazzoleni A; Farina C
    Minerva Ginecol; 2002 Jun; 54(3):245-51. PubMed ID: 12063440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Campaign against breast cancer. Are aromatase inhibitors the better choice? (interview by Dr. Dorothea Dlugosch)].
    Bruntsch U
    MMW Fortschr Med; 2002 Sep; 144(38):20. PubMed ID: 12395697
    [No Abstract]   [Full Text] [Related]  

  • 18. [Two new therapeutic principles in the management of breast cancer and colorectal cancer: selective oral aromatase inhibition and thymidilate synthase inhibition].
    Internist (Berl); 1997 Mar; 38(3 Suppl Selektive):1-16. PubMed ID: 9541667
    [No Abstract]   [Full Text] [Related]  

  • 19. Letrozole in breast cancer.
    Shahab N
    N Engl J Med; 2004 Feb; 350(7):727-30; author reply 727-30. PubMed ID: 14971058
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful use of letrozole in male breast cancer: a case report and review of hormonal therapy for male breast cancer.
    Zabolotny BP; Zalai CV; Meterissian SH
    J Surg Oncol; 2005 Apr; 90(1):26-30. PubMed ID: 15786432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.